The data reported here are generally aligned with another recent study that reported an increase of NP tau pathology after intracerebral AD-tau injection into APP/PS1 × TREM2−/− mice, as well as in APP/PS1 mice expressing human R47H TREM2 in the absence of endogenous mouse TREM2 [28]. Here, MAPT is linked to Alzheimer disease.